Nobuki Matsunami

A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer

Norikazu Masuda, Kenji Higaki, Toshimi Takano et al. · Cancer Chemotherapy and Pharmacology · 2014 · 38 citations

Medicine, Oncology, Pharmacology +16

Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer

Satoru Tanaka, Mitsuhiko Iwamoto, Kosei Kimura et al. · Clinical Breast Cancer · 2014 · 35 citations

Medicine, Oncology, Pharmacology +16

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY)

Shoichiro Ohtani, Takahiro Nakayama, Tetsuhiro Yoshinami et al. · Breast Cancer · 2018 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: evaluation of efficacy, safety, and patient-reported outcomes

Kosei Kimura, Mitsuhiko Iwamoto, Satoru Tanaka et al. · Cancer Chemotherapy and Pharmacology · 2018 · 13 citations

Medicine, Oncology, Pharmacology +16

Malignant phyllodes tumor with liposarcomatous components: A case report with cytological presentation

Takao Satou, Nobuki Matsunami, Chika Fujiki et al. · Diagnostic Cytopathology · 2000 · 12 citations

Medicine, Oncology, Pathology +17